share_log

SVB Securities Upgrades Elevation Oncology to Outperform, Raises Price Target to $8

Benzinga ·  May 30, 2023 06:59

SVB Securities analyst Andrew Berens upgrades Elevation Oncology (NASDAQ:ELEV) from Market Perform to Outperform and raises the price target from $5 to $8.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment